Skip to content

Clinical trials

Liver Cirrhosis trials in Hong Kong

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Liver Cirrhosis Country / region: Hong Kong Clear all

18 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20132
20141
20151
20171
20181
20193
20203
20213
20221
20231
20241

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed9
Active, not recruiting3
Recruiting2
Unknown status2
Terminated1
Withdrawn1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Chinese University of Hong Kong8
The University of Hong Kong3
AstraZeneca1
Azienda Ospedaliera Universitaria Integrata Verona1
Cook Research Incorporated1
European Foundation for Study of Chronic Liver Failure1
Galmed Research and Development, Ltd.1
SuperSonic Imagine1
Tobira Therapeutics, Inc.1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Liver Cirrhosis18
Non-alcoholic Fatty Liver Disease5
Fibrosis3
Liver Diseases3
Fatty Liver2
Hypertension, Portal2
Acute-On-Chronic Liver Failure1
Bone Diseases, Metabolic1
Diabetes Mellitus1
Gastritis1

Trials

Showing 1 to 18 of 18. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.